Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2008-03-04
2008-03-04
McGarry, Sean (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S024300, C536S024330
Reexamination Certificate
active
10831901
ABSTRACT:
The present invention provides design and synthesis of oligomeric compounds and compositions that can be administered to reduce the activity of SARS virus in vivo or in vitro, to prevent or treat SARS virus-associated disease, to detect AARS virus, and to diagnose SARS virus-associated diseases.
REFERENCES:
patent: 5707866 (1998-01-01), Brakier-Gingras
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5877309 (1999-03-01), McKay et al.
patent: 6180353 (2001-01-01), Dean et al.
patent: 1458281 (2003-11-01), None
patent: WO 95/27054 (1995-10-01), None
patent: WO 2004/092383 (2004-10-01), None
Kurreck et al. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Research, 2002 vol. 30, pp. 1911-1918.
“WHO Multicenter Collaborative Networks For Severe Acute Respiratory Syndrome (SARS),”Wkly. Epidemiol. Rec., 2003, 78<121-122.
Farabaugh, “Programmed translational frameshifting,”Microbiol. Rev.(1996) 60:103-134.
Gesteland and Atkins, “Recoding: dynaming reprogramming of translation,”Ann. Rev. Biochem.(1996) 65:741-768.
Giedroc, et al., “Structure, stability and function of RNA pseudoknots invoved in stimulating ribosomal frameshifting,”J. Mol. Biol.(2000) 298:167-185.
Egli, et al., “Metal Ions and flexibility in a viral RNA pseudoknot at atomic resolution,”Proc. Natl. Acad. Sci. USA(2002) 99:4302-4307.
Plant, et al., “The 9-A solution: how mRNA pseudoknots promote efficient programmed-1 ribosomal frameshifting,”RNA(2003) 9:168-164.
Vickers and Ecker, “Enhancement of ribosomal frameshifting by oligonucleotides targeted to the HIV gag-pol region,”Nucleic. Acids Res.(1992) 20:3945-3953.
Agrawal, S. et al., “Antisense therapeutics: is it as simple as complementary base recognition?”Mol. Med. Today(2000) 6:72-81.
Breierley, I. et al., “Expression of a Coronavirus Ribosomal Frameshift Signal inEscherichia coli: Influence of tRNA Anticodon Modification on Frameshifting,”J. Mol. Biol.(1997) 270:360-373.
Qin, L. et al., “Identification of probably genomic packaging signal sequence from SARS-CoV genome bioinformatics analysis,”Acta Pharmacol. Sin(2003) 24(6):489-496.
Shi, Y. et al., “Antisense downregulation of SARS-CoV gene expression in Vero E6 cells,”J. Gene Med.(2005) 7:97-107.
Snijder, E. J. et al., “Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage,”J. Mol. Bio.(2003) 331:991-1004.
PCT International Search Report for PCT/US04/13050 dated Apr. 13, 2005.
Supplementary European Search Report from PCT/US2004/013050 dated Jan. 22, 2007.
Abdou, et al, “Beta-cyclodextrin derivatives as carries to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence”, Archives of Virology, vol. 142, NR 8, pp. 1585-1602; XP002397673, (1997).
Drosten, et al, “Identification of a Novel Coronavirus in patients with severe acute respiratory syndrome” New England Journal of Medicine, Massachusetts Medical Society, vol. 348 No. 20, Apr. 10, 2003.
Philipkoski, Kristen “Stopping SARS: A search for drugs” Wired News, Apr. 28, 2003. http://wired.com
ews/medtech/1.58635-0.html.
Ksiazek, et al., “A Novel Coronavirus associated with Severe acute respiratory syndrome” New England Journal of Medicine, Massachusetts Medical Society, Boston, MA vol. 348, No. 20, Apr. 10, 2003.
Marra, et al., “The Genome Sequence of the SARS-associated coronavirsu” Science, American Association for the Advancement of Science US vol. 300 No. 5624. pp. 1399-1404, May 30, 2003.
Rota, et al, “Characterization of a novel coronavirus associated with severe acute respiratory syndrome” Science American Association for the Advancement of Science, vol. 300, No. 5624, May 30, 2003. pp. 1394-1399.
Supplemental partial European Search Report for EP 04809344.7 mailed on Oct. 24, 2006.
Baker Brenda F.
Bennett C. Frank
Crooke Stanley T.
Ecker David J.
Freier Susan M.
Gibbs Terra Cotta
Isis Pharmaceuticals , Inc.
Knobbe, Martens Olson, and Bear, LLP.
McGarry Sean
LandOfFree
Compositions and methods for the treatment of severe acute... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the treatment of severe acute..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment of severe acute... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3922486